Brief: Immutep Signs Exclusive License Agreement With Cardiff University For Next Generation Anti-Lag-3 Molecules For Cancer
25/06/2024 13:37
June 25 (Reuters) - Immutep Ltd IMM.AX :
* IMMUTEP SIGNS EXCLUSIVE LICENSE AGREEMENT WITH CARDIFF
UNIVERSITY FOR NEXT GENERATION ANTI-LAG-3 MOLECULES FOR CANCER
Source text for Eikon: ID:nGNX7VdZNb
Further company coverage: IMM.AX
((Reuters.Briefs@thomsonreuters.com;))